Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Efficacy of artificial intelligence-driven conversational agents (chatbots) for mental health promotion among university students: a systematic review and meta-analysis

AI Summary
  • AI conversational agents reduced depressive and anxiety symptoms versus non-active or low-intensity comparators (Hedges g ≈ -0.41 to -0.44); evidence certainty low.
  • No clear incremental benefit versus active conversational controls (MYLO) for depression or anxiety; estimates very uncertain.
  • Evidence base small, clinically heterogeneous, reliant on self-report, limited generalisability; prioritise secure, consent-based, human-supervised implementation and objective outcome assessment.
Summarise with AI (MRCPsych/FRANZCP)

Front Psychiatry. 2026 Oct 9;17:1824378. doi: 10.3389/fpsyt.2026.1824378. eCollection 2026.

ABSTRACT

BACKGROUND: University students experience substantial mental-health burdens, while access to timely support remains uneven. AI conversational agents may provide low-threshold support, but the evidence base has expanded rapidly and prior reviews have often combined different age groups, intervention types, outcome domains, and comparator conditions.

OBJECTIVE: To evaluate the effects of AI-mediated conversational interventions on depressive and anxiety symptoms in university students, while distinguishing outcome domains, comparator intensity, intervention architecture, and the evidential requirements for standardized post-intervention effect estimation.

METHODS: We updated the search in PubMed, Embase, PsycINFO, CENTRAL, and Web of Science to the revised search date and rebuilt an auditable cross-database record ledger. The updated workflow included 3,786 exported records, 451 DOI/PMID duplicates, 41 confirmed title/author duplicates, and 3,294 unique records screened. All title/abstract records completed a two-reviewer screening and consensus chain. Forty-six update-search records entered research-level/full-text assessment. Randomized controlled trials were eligible for causal quantitative synthesis; relevant feasibility, acceptability, usability, and non-comparable controlled studies were retained narratively. Standard post-intervention analyses used Hedges g, REML random-effects models, and Hartung-Knapp adjustment, and were restricted to attributable two-group post-intervention data.

RESULTS: In the final locked non-active/low-intensity comparator analysis, three depression comparisons favored conversational interventions (k=3; Hedges g=-0.413, 95% CI -0.557 to -0.268; I2 = 0.0%) and four anxiety comparisons also favored them (k=4; Hedges g=-0.435, 95% CI -0.603 to -0.268; I2 = 2.1%). In the separate active conversational-control analysis, two MYLO comparisons did not show a reliable incremental effect for depression (k=2; g=0.165, 95% CI -0.580 to 0.911) or anxiety (k=2; g=0.190, 95% CI -0.556 to 0.937). The evidence base remained small, clinically heterogeneous, and limited by attrition, self-reported outcomes, and uncertainty regarding generalizability.

CONCLUSIONS: AI conversational interventions may improve depressive and anxiety symptoms relative to non-active or low-intensity comparators in university students, but the certainty of evidence is low and estimates are based on few comparisons. Evidence against active conversational controls is very uncertain. Outcome-domain differences and architecture-related claims should be treated as hypothesis-generating. Secure, consent-based, human-supervised implementation and objective outcome assessment are priorities for future research.

SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261323382, identifier CRD420261323382.

PMID:42920674 | PMC:PMC13690801 | DOI:10.3389/fpsyt.2026.1824378

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD